Grifols, S.A. (NASDAQ:GRFS) Q1 2025 Earnings Call Transcript
Danny Segarra: Hello, everyone. My name is Danny Segarra, and myself as the Head of Investor Relations and Sustained and Vice President, Grifols.
Grifols Sa (GRFS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Permian Investment Partners Alex Duran And Scott Hendrickson | 18,081,321 | $128,558,192 | +12% | 18.29% |
| 2. | Armistice Capital Steven Boyd | 9,278,000 | $65,966,580 | -8% | 0.99% |
| 3. | Millennium Management Israel Englander | 8,568,935 | $60,925,128 | -9% | 0.03% |
| 4. | Soleus Capital Guy Levy | 7,089,822 | $50,408,634 | +8% | 3.63% |
| 5. | Harris Associates Natixis Global Asset Management | 3,439,000 | $24,451,290 | -8% | 0.04% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 25,741,348 | $183,020,985 | 1.86% | |
| 2. | 21,522,236 | $153,023,098 | 0.02% | |
| 3. | 12,690,887 | $90,232,207 | 4.23% | |
| 4. | 4,212,032 | $29,947,547 | 0% | |
| 5. | 3,045,260 | $22,184,719 | 0.01% |
News See All
Here’s White Falcon's Views on Grifols, S.A. (GRFS)
White Falcon Capital Management, an investment fund manager, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
12 Best Low Price Pharma Stocks To Invest In Right Now
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...
Grifols, S.A. (NASDAQ:GRFS) Q1 2024 Earnings Call Transcript
Daniel Segarra: Hello, everyone, and welcome to Grifols' Conference Call. Today, we will be sharing a business update on our first quarter financial results.
Grifols, S.A. (NASDAQ:GRFS) Q3 2023 Earnings Call Transcript
Nuria Pascual: Hello, everyone, and welcome to the Grifols Third Quarter 2023 Conference Call. Thank you very much for taking the time to join us today.
Grifols, S.A. (NASDAQ:GRFS) Q2 2023 Earnings Call Transcript
Nuria Pascual: Hello everyone, and welcome to the Grifols' Second Quarter 2023 Conference Call. Thank you very much for taking the time to join us today.
10 Best Pharma Stocks To Buy Now
With a compound annual growth rate (CAGR) of 9.1%, the global pharmaceuticals industry is projected to expand to $1587.1 billion in 2022 from $1454.7 billion in 2021.
10 Best Low Price Pharma Stocks To Buy Now
The global pharmaceuticals market was forecasted to grow from $1454.66 billion in 2021 to $1587.05 billion in 2022 at a compound annual growth rate (CAGR) of 9.1%.
10 Best Medical Stocks Under $10
According to the Centers for Medicare and Medicaid Services, U.S spending on national healthcare touched $4.1 trillion in 2020, which amounts to an expenditure of $12,530 per person.
Is GRFS A Good Stock To Buy Now?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Billionaire Hedge Funds
